XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash Flows From Operating Activities:    
Net loss $ (53,307) $ (90,098)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share-based compensation expense 6,231 8,715
Gain on change in fair value of SAFE and warrant liabilities (20,322) (4,663)
Loss on change in fair value of the FPA Put Option and the Fixed Maturity Consideration liabilities 23,998 33,029
Recoveries and provision for losses on trade and other receivables (700) 800
Depreciation of property, plant and equipment 2,988 2,605
Amortization of discount on debt security investment (501) (508)
Non-cash lease expense 887 387
Non-cash recognition of licensing revenue (9,240) (1,136)
Loss from equity method investees, net 2,400 478
Net foreign exchange gain (131) 194
Changes in operating assets and liabilities:    
Accounts receivable, net 3,575 3,129
Contract assets 1,034 (3,668)
Accrued interest on debt investment 120 (93)
Other assets (2,269) (8,942)
Accounts payable and accrued salaries and wages 458 1,881
Contract liabilities 128 (150)
Operating lease liabilities 507 (19)
Other liabilities 1,202 (1,057)
Net cash used in operating activities (42,942) (59,116)
Cash Flows From Investing Activities:    
Purchase of property, plant and equipment (3,268) (5,318)
Purchase of debt securities 0 (49,103)
Proceeds from maturity of debt securities 32,770 0
Purchase of additional interest in equity method investment 0 (288)
Origination of related party loan 0 (5,212)
Net cash provided by/ (used in) investing activities 29,502 (59,921)
Cash Flows From Financing Activities:    
Proceeds from issue of equity instruments of the Company 272 1,077
Proceeds from the Business Combination and PIPE, net of transaction expenses (Note 3) 0 213,381
Forward Purchase Agreement prepayment 0 (60,096)
Repurchase of equity instruments of the Company (48) (7,650)
Net cash provided by financing activities 224 146,712
Net decrease in cash, cash equivalents and restricted cash (13,216) 27,675
Cash, cash equivalents and restricted cash at beginning of period 76,284 83,710
Effects of currency translation on cash, cash equivalents and restricted cash (177) 4
Cash, cash equivalents and restricted cash at end of period 62,891 111,389
Supplemental disclosure of non-cash investing and financing activities:    
Acquisition of property, plant and equipment under accounts payable 235 125
Right-of-use asset additions 8,934 0
Reclassification of capitalized costs related to the business combination to equity 0 1,514
Cashless conversion of warrants on preferred shares 0 5,890
Recognition of public and private warrant liabilities in the Business Combination 0 4,624
Reclassification of AM SAFE warrant to equity 0 1,800
Conversion of AM SAFE liability into common stock 0 29,730
Conversion of Legacy LanzaTech NZ, Inc. preferred stock and in-kind dividend into common stock 0 722,160
Reclassification of Shortfall warrant to equity $ 0 $ 3,063